C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2004
11/25/2004	WO2004100773A2 Diagnostic and therapeutic treatments related to mitochondrial disorders
11/25/2004	WO2004091637A3 System capable of treating and defining various diseases using stem cells
11/25/2004	WO2004071443A3 Methods and compositions for modulating stem cells
11/25/2004	WO2004070027A3 Method for modifying plant growth characteristics
11/25/2004	WO2004069272A3 Adjuvant combination for use in the immunization of a mamal comprising il2 and il12
11/25/2004	WO2004063346A3 Lysozyme transgenic ungulates
11/25/2004	WO2004048601A3 Modulation of b7h expression
11/25/2004	WO2004035761A3 Bone marrow cell differentiation
11/25/2004	WO2004033625A3 Urocortin-deficient mice and uses thereof
11/25/2004	WO2004003142A3 Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
11/25/2004	WO2003096972A3 Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
11/25/2004	WO2003070197A3 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/25/2004	US20040237153 Soybean cultivar 0487681
11/25/2004	US20040237152 Soybean cultivar 0491717
11/25/2004	US20040237145 Control of gene expression
11/25/2004	US20040237139 Production of hydroxylated fatty acids in genetically modified plants
11/25/2004	US20040237134 Wheat plants having increased resistance to imidazoline herbicides
11/25/2004	US20040237132 Plant promoters
11/25/2004	US20040237130 Propagating conifer somatic embryos; preparing nutrient broth comprising combinations of glucose and maltose, inoculate with conifer explants recover embryonic suspensor masses; tissue engineering
11/25/2004	US20040237127 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
11/25/2004	US20040236342 Device to assess ADR motion
11/25/2004	US20040236095 formed by readcting chitosan with iminothiolane; improved viscoelasticity and gelation; for use in hair gels, eye drops, stents, and tissue engineering
11/25/2004	US20040236087 Moraxella(branhamella) catarrhalis antigens
11/25/2004	US20040236081 Immunoglobulin which binds interleukkin-1bconverting enzyme for use in diagnosis, treatment and prevention of autoimmune, neurodegenerative and cell proliferative disorders
11/25/2004	US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004	US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004	US20040235764 Methods of inhibiting expression of a target gene in mammalian cells
11/25/2004	US20040235743 Soluble zalpha11 cytokine receptors
11/25/2004	US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004	US20040235174 Adenoviral expression vector comprising red fluorescent protein reporter for use as heterologous gene transfer tool
11/25/2004	US20040235172 Antigen transduced t cells used as a delivery system for antigens
11/25/2004	US20040235171 Using post-transcriptional silencing to treat cell proliferative disorders associated with human papiloma viral infection; RNA interference; antitumor/antiviral agents
11/25/2004	US20040235170 Prosthetic grafts
11/25/2004	US20040235168 Method of manufacturing a culture medium
11/25/2004	US20040235167 Biological scaffold for patterened propagation of preferential tissues; tissue engineering; cell replacement therapy
11/25/2004	US20040235166 Using cell proliferative agent, dickkopf-1 (DKK-1), to intensify the multipotentiality of mesenchhymal stem cells; for use in cell replacement therapy; tissue engineering
11/25/2004	US20040235165 Using mesenchymal stem cells to propagate neuronal, renal, chondrocytic, moncytic, hepatocytic and/or cardiomycitic cells for use in cell replacement therapies associated with organ tissue damages; tissue engineering
11/25/2004	US20040235163 Comprises regulatory agent which prevents apoptosis and/or cardiac oxidative stress in myocardial tissues; identifying modulators of atp sensitive potassium channels
11/25/2004	US20040235162 Using nutrient broth comprising interleukin 10 and transforming growth factor to propagate dendritic cells for use in treatment and prevention of graft rejection, autoimmune, allergic and graft vs host diseases
11/25/2004	US20040235161 Artificial kidney having function of metabolizing protein and method of constructing the same
11/25/2004	US20040235160 Process for preparing hematopoietic stem cells
11/25/2004	US20040235159 Using nutrient broth comprising cell proliferative agents and mouse embryonic fibroblasts to propagating pluripotent stem cells for use in cell replacement therapies
11/25/2004	US20040235158 Using size exclusion and cell surface marker discrimination to separate and generate homogenous cell population for use in tissue replacement therapies associated with nervous system disorders
11/25/2004	US20040235157 Transgenic cell line for use as tools in identification of signal transduction modulators; diagnostic assay comprising enhanced shelf life
11/25/2004	US20040235156 Therapeutic mixture comprising interferons and chimeric immunoglobulins for use in activation of immune response and treatment, diagnosis and prevention of cancer; immunotherapy; tissue targeted therapy
11/25/2004	US20040235151 Device and method for cultivation
11/25/2004	US20040235132 Helper cell comprising coronavirus permissive cell, replicon RNA and helper RNA: for use in producing assembled coronavirus particles which comprise heterologous RNA sequences, is able to infect cells and is unable to complete viral replication in absence of helper RNA; heterologous gene expression
11/25/2004	US20040235129 KDEL receptor inhibitors
11/25/2004	US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004	US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004	US20040235113 18 human secreted proteins
11/25/2004	US20040235110 Immunoglobulin for use in identifying polypeptides which inhibit cell proliferation; immunoassay; immunodiagnostics
11/25/2004	US20040235102 Comprises adenosine triphosphate binding cassette membrane protein for use in identifying modulator which prevent transport of neurotoxic molecules; treating nervous system disorders
11/25/2004	US20040235100 Renilla reniformis green fluorescent protein and mutants thereof
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040235096 Method for regulating dopamine producing cells
11/25/2004	US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases
11/25/2004	US20040235091 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer
11/25/2004	US20040235070 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
11/25/2004	US20040235058 ULBP antibodies
11/25/2004	US20040235038 Using single-stranded conformational polymorphisms to identify mutation which lead to cardiovascular disorders; identifying modulator for treatment of cardiac disorders
11/25/2004	US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234976 Comprises nucleotide sequences coding aspartyl protease for use in identifying modulators for treatment and prevention of nervous system disorders
11/25/2004	US20040234973 Using cytosine methylation to diagnose cancer disorders
11/25/2004	US20040234972 Transfecting pluripotent/totipotent cells with constructs comprising smooth muscle specific promoter/enhancer sequences, monitoring cells which provide reporter response, determine lineage/classification; tissue engineering and cell differentiation
11/25/2004	US20040234959 Truncated bard1 protein, and its diagnostic and therapeutic uses
11/25/2004	US20040234947 Cells for detection of influenza and parainfluenza viruses
11/25/2004	US20040234941 Apparatus for and methods of preparing sperm
11/25/2004	US20040234578 Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
11/25/2004	US20040234547 Composition for the delivery of live cells and methods of use thereof
11/25/2004	US20040234538 Genetic engineered polypeptide; induce immunology response
11/25/2004	US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004	US20040234521 Antigen detection segments; crosslinking receptors
11/25/2004	US20040234518 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
11/25/2004	US20040234511 Genetic engineering white blood cells in vitro; gene expression of antigen; insertion into mammals
11/25/2004	US20040234510 Extracellular matrices controlling morphology, cellular differentiastion, cellular proliferation, gene expression; transplanting; seeding; culturing
11/25/2004	US20040234509 Replacing liver cells with bone marrow-derived cells for treating disease and expressing therapeutic genes
11/25/2004	US20040234508 Arrangement with artificial neurons for describing the transmission behavior of a nerve cell to be excited and method for determining the transmission behavior of a nerve cell to be excited using artificial neurons
11/25/2004	US20040234500 Method for inducing proliferation of retinal stem cells
11/25/2004	US20040234498 Inducing apoptosis in mammalian cancer cellsl stimulanting a proinflammatory response ; polypeptides; tumor necrosis factor
11/25/2004	US20040234472 Micellar drug delivery systems for hydrophobic drugs
11/25/2004	CA2526933A1 Composition for maintaining organ and cell viability
11/25/2004	CA2526451A1 Artificial immune organ
11/25/2004	CA2525909A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	CA2525870A1 Liver x receptor .alpha. splicing mutant protein, gene thereof and use thereof
11/25/2004	CA2525712A1 Organism-culture apparatus and culture method
11/25/2004	CA2525560A1 Diagnostic and therapeutic treatments related to mitochondrial disorders
11/25/2004	CA2525385A1 Grp94-based compositions and methods of use thereof
11/25/2004	CA2524496A1 Three dimensional cell cultures in a microscale fluid handling system
11/25/2004	CA2523943A1 Compositions and methods for wt1 specific immunotherapy
11/25/2004	CA2523785A1 Small interfering rna libraries and methods of synthesis and use
11/24/2004	EP1479767A1 Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring notch gene
11/24/2004	EP1479763A2 Mutant luciferase having increased thermostability
11/24/2004	EP1479760A1 Artificial immune organ
11/24/2004	EP1479690A1 Cytokine isolated from an insect

1 ... 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 ... 1827